※一部利用できない機能があります
腹膜播種患者に対するタキサン系抗癌剤の腹腔内投与時における腹水および血漿中濃度推移
- フォーマット:
- 論文
- 責任表示:
- 古居, 奈歩 ; 山崎, 賢 ; 横川, 弘一 ; 伏田, 幸夫 ; 三輪, 晃一 ; 宮本, 謙一
- 言語:
- 日本語
- 出版情報:
- 日本医療薬学会 = Japanese Society of Pharmaceutical Health Care and Sciences, 2003-06-10
- 著者名:
古居, 奈歩 山崎, 賢 横川, 弘一 伏田, 幸夫 三輪, 晃一 宮本, 謙一 - 掲載情報:
- 医療薬学 = Japanese Journal of Pharmaceutical Health Care and Sciences
- ISSN:
- 1346-342x
- 巻:
- 29
- 通号:
- 3
- 開始ページ:
- 263
- 終了ページ:
- 269
- バージョン:
- publisher
- 概要:
- We evaluated the disposition kinetics of taxanes, an antitumor agent after the intraperitoneal administration in nine patients with peritoneal tumors. The intraperitoneal concentrations of docetaxel or paclitaxel decreased slowly following the i.p. infusion administration of either docetaxel (60-80mg/day) or paclitaxel (120-180mg/ day) over a 1-hour period in patients. There was no difference in the concentration-time courses between both drugs in each patient, … and the elimination half-time was about 8hr. The area under the intraperitoneal concentration-time curve (AUCp) of paclitaxel relative to the dose was about 3-times larger than that of docetaxel. On the other hand, the permeability of these drugs from the peritoneal cavity into the systemic circula-tion was extremely small. The plasma concentrations and the AUCs of both drugs showed large individual variations among the patients. The ratios of AUCs/AUCp of docetaxel and paclitaxel relative to the dose were 7.1 ×10-2and 3.8×10-3, respectively. The permeability of paclitaxel was only about 1/20 that of docetaxel. 続きを見る
- URL:
- http://hdl.handle.net/2297/36334
類似資料:
日本医療薬学会 |
へるす出版 |
日本臨床薬理学会 = The Japanese Society of Clinical Pharmacology and Therapeutics |
日本医療薬学会 = Japanese Society of Pharmaceutical Health Care and Sciences |
日本薬学会 = The Pharmaceutical Society of Japan |
日本医療薬学会 = Japanese Society of Phamaceutical Health care and Sciences |
第四高等學校十全會 | |
癌と化学療法社 |
金沢大学医薬保健研究域医学系 |
金沢大学医薬保健研究域医学系 |
金沢大学医薬保健研究域医学系 |